The Refacto market is witnessing steady growth over the forecast period, supported by expansion of long-acting clotting factor products, rising demand for personalized hemophilia care.
Read More
The Recothrom market is witnessing steady growth over the forecast period, supported by increasing demand for plasma-free hemostatic solutions, rising focus on infection risk reduction.
Read More
The Recombivax, Recombivax Hb market is witnessing steady growth over the forecast period, supported by increasing focus on adult booster immunization, rising investments in vaccine self-sufficiency.
Read More
The Recombinate market is witnessing steady growth over the forecast period, supported by increasing adoption of long-acting clotting factors, rising investments in gene and protein therapies.
Read More
The Rebyota market is witnessing steady growth over the forecast period, supported by rising incidence of recurrent cdi, expanding regulatory support for microbiome drugs.
Read More
The Reblozyl market is witnessing steady growth over the forecast period, supported by growing demand for transfusion-sparing therapies, expansion of biologics in hematology care.
Read More
The Rebinyn Or Refixia market is witnessing steady growth over the forecast period, supported by growing demand for convenient hemophilia management options, expansion of home-based treatment models.
Read More
The Rebif market is witnessing steady growth over the forecast period, supported by increasing adoption of personalized ms treatment plans, rising demand for home-based injectable therapies.
Read More
The Raplixa market is witnessing steady growth over the forecast period, supported by increasing demand for minimally invasive surgeries, rising focus on reducing surgical complications.
Read More
The Ragwitek market is witnessing steady growth over the forecast period, supported by increasing adoption of preventive allergy therapies, expansion of personalized allergy immunotherapy.
Read More